Want to keep learning?

This content is taken from the Uppsala University's online course, Antibiotic Resistance: the Silent Tsunami. Join the course to learn more.
Stacked books.

Further reading

We’ve compiled a list of resources for those who want to dedicate more time and continue to explore antibiotic resistance. At the bottom of this page, you’ll also find a reference list of this course.


World Health Organization (WHO)

European Centre for Disease Prevention and Control (ECDC)

Centers for Disease Control and Prevention (CDC)

Center for Disease Dynamics, Economics & Policy (CDDEP)

World Organisation for Animal Health (OIE)

Food and Agriculture Organization of the United Nations (FAO)

Action on Antibiotic Resistance (ReAct)


Tackling Drug-Resistant Infections Globally: final report and recommendations by AMR Review (2016)

National Action Plan for Combating Antibiotic-Resistant Bacteria by the White House (2015)

Global Action Plan on Antimicrobial Resistance by WHO (2015)

Worldwide Country Situation Analysis: Response to Antimicrobial Resistance by WHO (2015)

Antibiotic Resistance: Multi-country public awareness survey by WHO (2015)

Antimicrobial Resistance: Global Report on Surveillance by WHO (2014)

New Business Models for Sustainable Antibiotics by Chatham House (2014)

Antibiotic Resistance Threats in the United States by CDC (2013)


Hassing RJ, Alsma J, Arcilla MS, van Genderen PJ, Stricker BH, Verbon A. International travel and acquisition of multidrug-resistant Enterobacteriaceae: a systematic review. Euro Surveill. 2015;20(47).

Heyman G, Cars O, Bejarano MT, Peterson S. Access, excess, and ethics – towards a sustainable distribution model for antibiotics. Ups J Med Sci. 2014 May;119(2):134-141.

Hughes D, Karlén A. Discovery and preclinical development of new antibiotics. Ups J Med Sci. 2014 May; 119(2):162-169.

Jasovsky D, Littmann J, Zorzet A, Cars C. Antimicrobial Resistance – A Threat to the World’s Sustainable Development. Development dialogue paper, no 16, 2016.

Tängdén T, Adler M, Cars O, Sandegren L, Löwdin E. Frequent emergence of porin-deficient subpopulations with reduced carbapenem susceptibility in ESBL-producing Escherichia coli during exposure to ertapenem in an in vitro pharmacokinetic model. J Antimicrob Chemother. 2013 Jun;68(6):1319-1326.

Share this article:

This article is from the free online course:

Antibiotic Resistance: the Silent Tsunami

Uppsala University